United Kingdom Digital Diabetes Management Market Insight
Published: 27 June 2026 | Report Format: Electronic (PDF) | Author: Aditi and Govind
The United Kingdom Digital Diabetes Management Market is anticipated to grow at a CAGR of 12.8% during the forecast period, driven by the rising prevalence of diabetes, increasing adoption of continuous glucose monitoring technologies, expanding telehealth services, growing integration of artificial intelligence into diabetes care, and supportive government initiatives promoting digital healthcare solutions across the country
United Kingdom Digital Diabetes Management Market Forecasts to 2035
- The United Kingdom Digital Diabetes Management Market Size was estimated at USD 0.78 Billion in 2025.
- The market size is expected to grow at a CAGR of around 12.8% from 2025 to 2035.
- The United Kingdom Digital Diabetes Management Market Size is expected to reach around USD 2.60 Billion by 2035.
Notable Insights in the United Kingdom Digital Diabetes Management Market
- Segmentation Based on Product Type, the Continuous Glucose Monitoring (CGM) Systems segment dominated the market in 2025 with nearly 46.8% share, supported by growing demand for real-time glucose tracking, improved glycemic control, and increasing adoption among individuals with Type 1 and Type 2 diabetes.
- Segmentation Based on End User, the Home Care Settings segment accounted for approximately 51.4% of market revenue in 2025, driven by increasing preference for remote diabetes monitoring, expanding use of connected health devices, and wider availability of digital self-management platforms.
- DexCom, Inc. reported USD 4.62 Billion in revenue during fiscal 2025, while Abbott Laboratories generated USD 42.67 Billion, reflecting continued investment in continuous glucose monitoring technologies, digital diabetes platforms, and connected patient care solutions.
- Medtronic plc recorded USD 33.51 Billion in revenue during fiscal 2025, while Roche Holding AG generated USD 68.41 Billion, highlighting sustained innovation across diabetes management devices, digital health ecosystems, remote monitoring technologies, and integrated care solutions.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom digital diabetes management market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in the United Kingdom Digital Diabetes Management Market
-
- Abbott Laboratories
- DexCom, Inc.
- Medtronic plc
- Roche Holding AG
- Insulet Corporation
- Ascensia Diabetes Care
- Tandem Diabetes Care, Inc.
- Novo Nordisk A/S
- Ypsomed AG
- Senseonics Holdings, Inc.
Recent Developments:
- In October 2025, Abbott Laboratories launched an upgraded FreeStyle Libre digital diabetes management solution across selected European markets, enhancing glucose monitoring accuracy, smartphone connectivity, and personalized diabetes insights for patients and healthcare professionals.
- In June 2025, DexCom, Inc. collaborated with Ypsomed AG to strengthen interoperability between continuous glucose monitoring systems and automated insulin delivery solutions, improving integrated diabetes care for people living with insulin-dependent diabetes.
Market Segmentation:
United Kingdom Digital Diabetes Management Market, By Product Type
- Continuous Glucose Monitoring (CGM) Systems
- Smart Insulin Pens
- Insulin Pumps
- Diabetes Management Software
- Mobile Health Applications
United Kingdom Digital Diabetes Management Market, By Device Connectivity
- Smartphone Connected Devices
- Cloud-Based Platforms
- Wearable Devices
United Kingdom Digital Diabetes Management Market, By End User
- Home Care Settings
- Hospitals
- Diabetes Clinics
- Ambulatory Care Centers
- Others
United Kingdom Digital Diabetes Management Market, By Diabetes Type
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
United Kingdom Digital Diabetes Management Market, By Region
- England
- Scotland
- Wales
- Northern Ireland
Expert Views:
The United Kingdom digital diabetes management market is expected to witness robust growth through 2035, supported by increasing adoption of connected glucose monitoring technologies, expanding digital health infrastructure, and greater emphasis on personalized diabetes care. Companies focusing on AI-powered analytics, device interoperability, patient engagement platforms, and strategic collaborations are well positioned to strengthen their competitive advantage while addressing the country's growing demand for efficient, data-driven diabetes management solutions.
Author: Aditi and Govind By Decisions Advisors and Consulting